Leukemia - More Stories

	Jan 05, 2012 Ponatinib Overcomes Tricky Mutation in CML BY ELIZABETH WHITTINGTON A novel drug called ponatinib that targets the BCR-ABL mutation overcomes a mutation that has been resistant to all previous approved therapies.
	Jan 03, 2012 Different Dosing Schedule May Revive Withdrawn Drug BY ELIZABETH WHITTINGTON A drug removed from the market last year to treat acute myeloid leukemia may have a second life.
	Dec 21, 2011 Pipeline BY LINDSAY RAY The latest in cancer prevention, diagnosis and treatment.
	Dec 21, 2011 Research Updates BY ELIZABETH WHITTINGTON Research updates from the annual San Antonio Breast Cancer Symposium and American Society of Hematology.
	Jun 13, 2011 For Acute Lymphoblastic Leukemia Patients, New Hope from an Old Treatment New research has shown that high-dose methotrexate improved five-year event-free survival for ALL patients with no significant differences in toxicities.
	Mar 15, 2011 Transplants More Effective for Young Adults with AML BY ELIZABETH WHITTINGTON Adolescents with AML tend to do better with stem cell transplant.
	Dec 29, 2010 Pediatric Regimen Better for Young Adults with AML BY ELIZABETH WHITTINGTON Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.
	Dec 29, 2010 Bosutinib Joins Crowd of CML-Focused Drugs BY ELIZABETH WHITTINGTON Chronic myeloid leukemia (CML)usually can be managed as a chronic disease by therapies, including Gleevec (imatinib) or two newer drugs, Sprycel (dasatinib) or Tasigna (nilotinib).
	Dec 29, 2010 Phase 1 Trial of Ponatinib Shows Early Success in CML BY ELIZABETH WHITTINGTON Study shows experimental drug ponatinib acts against a mutation found in small percentage of chronic myeloid leukemia cases that is resistant to other forms of therapy
	Dec 20, 2010 Treatment Updates BY STAFF REPORTS Updates from the annual meetings of the American Society of Hematology and the San Antonio Breast Cancer Symposium.